Fresenius Medical Care Management
Management criteria checks 2/4
Fresenius Medical Care's CEO is Helen Giza, appointed in Nov 2019, has a tenure of 4.5 years. total yearly compensation is €5.53M, comprised of 30.1% salary and 69.9% bonuses, including company stock and options. directly owns 0.005% of the company’s shares, worth €543.78K. The average tenure of the management team and the board of directors is 2.3 years and 0.4 years respectively.
Key information
Helen Giza
Chief executive officer
€5.5m
Total compensation
| CEO salary percentage | 30.1% |
| CEO tenure | 4.5yrs |
| CEO ownership | 0.005% |
| Management average tenure | 2.3yrs |
| Board average tenure | less than a year |
Recent management updates
Recent updates
Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19
Apr 26
Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 29Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19
Mar 14Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19
Feb 23When Should You Buy Fresenius Medical Care AG (ETR:FME)?
Feb 22Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings
Feb 03Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital
Jan 16Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?
Dec 29Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?
Nov 21Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal
Oct 16Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?
Sep 28Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?
Aug 21An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued
Jul 23Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture
Jul 09These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively
Jun 25What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?
May 07Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?
Apr 23We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt
Mar 24Should You Think About Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME) Now?
Feb 03Are Investors Undervaluing Fresenius Medical Care AG & Co. KGaA (ETR:FME) By 45%?
Jan 19Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively
Jan 04Fresenius Medical Care KGaA (ETR:FME) Takes On Some Risk With Its Use Of Debt
Dec 17Fresenius Medical Care KGaA's (ETR:FME) Anemic Earnings Might Be Worse Than You Think
Nov 08Is It Too Late To Consider Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?
Oct 25Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?
Sep 15Fresenius Medical Care KGaA (ETR:FME) Might Be Having Difficulty Using Its Capital Effectively
Aug 10CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | €6m | €2m | €499m |
| Sep 30 2023 | n/a | n/a | €450m |
| Jun 30 2023 | n/a | n/a | €596m |
| Mar 31 2023 | n/a | n/a | €602m |
| Dec 31 2022 | €3m | €1m | €673m |
| Sep 30 2022 | n/a | n/a | €763m |
| Jun 30 2022 | n/a | n/a | €806m |
| Mar 31 2022 | n/a | n/a | €878m |
| Dec 31 2021 | €2m | €855k | €969m |
| Sep 30 2021 | n/a | n/a | €918m |
| Jun 30 2021 | n/a | n/a | €998m |
| Mar 31 2021 | n/a | n/a | €1b |
| Dec 31 2020 | €2m | €855k | €1b |
| Sep 30 2020 | n/a | n/a | €1b |
| Jun 30 2020 | n/a | n/a | €1b |
| Mar 31 2020 | n/a | n/a | €1b |
| Dec 31 2019 | €2m | €108k | €1b |
Compensation vs Market: Helen's total compensation ($USD5.90M) is about average for companies of similar size in the German market ($USD5.55M).
Compensation vs Earnings: Helen's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Helen Giza (55 yo)
4.5yrs
Tenure
€5,528,000
Compensation
Ms. Helen Giza is Chief Executive Officer and Chair of the Management Board of Fresenius Medical Care Management AG, General Partner of Fresenius Medical Care AG & Co. KGAA from December 6, 2022. She serve...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chair of Management Board of Fresenius Med. Care Mgmt AG | 4.5yrs | €5.53m | 0.0047% € 543.8k | |
| CFO & Member of the Management Board of Fresenius Medical Care Management AG | less than a year | €887.00k | no data | |
| Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG | 4.3yrs | €3.13m | 0.0062% € 718.1k | |
| Management Board Member for Care Enablement of Fresenius Medical Care Management AG | 2.3yrs | €3.71m | 0.0039% € 449.7k | |
| CEO of Care Delivery & Member of Management Board | less than a year | no data | no data | |
| Executive VP and Head of Investor Relations | no data | no data | no data | |
| Senior Vice President of Corporate Communications & Governmental Affairs | no data | no data | no data | |
| Senior Vice President of Research & Development | no data | no data | no data | |
| Senior Vice President of Manufacturing and Supply Chain Operations | no data | no data | no data | |
| Senior Vice President - Quality Management International | no data | no data | no data | |
| Executive Vice President of Western Europe & Nephrocare Coordination EMEALA | no data | no data | no data | |
| Executive Vice President of Latin America | no data | no data | no data |
2.3yrs
Average Tenure
56yo
Average Age
Experienced Management: FME's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Member of Supervisory Board | less than a year | €20.00k | no data | |
| Chairman of the Supervisory Board | less than a year | €444.00k | no data | |
| Independent Member of Supervisory Board | 8yrs | €230.00k | no data | |
| Independent Member of Supervisory Board | less than a year | €21.00k | no data | |
| Independent Member of Supervisory Board | 3yrs | €151.00k | no data | |
| Employee Representative Deputy Chairwoman of the Supervisory Board | less than a year | no data | no data | |
| Member of Supervisory Board | less than a year | €158.00k | no data | |
| Employee Representative Member of Supervisory Board | less than a year | no data | no data | |
| Employee Representative Member of the Supervisory Board | less than a year | no data | no data | |
| Employee Representative Member of the Supervisory Board | less than a year | no data | no data | |
| Employee representatives Member of the Supervisory Board | less than a year | no data | no data | |
| Employee representatives Member of the Supervisory Board | less than a year | no data | no data |
0.4yrs
Average Tenure
55yo
Average Age
Experienced Board: FME's board of directors are not considered experienced ( 0.4 years average tenure), which suggests a new board.